Meeting
2014 ASCO Annual Meeting
Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma.
Authors
Jonathan S. Cebon
Ludwig Institute for Cancer Research, Melbourne, Australia
Jonathan S. Cebon , Grant A. McArthur , Weisan Chen , Ian D. Davis , Martin Eric Gore , John F Thompson , Michael Millward , Michael P. N. Findlay , Rod Dunbar , Christian H.H Ottensmeier , Ralph Rudolph Venhaus , Paul D. Nathan , Angus George Dalgleish , Vincenzo Cerundolo , Eugene Maraskovsky , Wendie Hopkins , Jeremy Marsden , B Mark Smithers , Peter Hersey , T.R. Jeffry Evans
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Melanoma/Skin Cancers
Clinical Trial Registration Number
NCT00199901
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 9050)
DOI
10.1200/jco.2014.32.15_suppl.9050
Abstract #
9050
Poster Bd #
254
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
A phase II open labeled, randomized study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared to Montanide, in melanoma patients in complete clinical remission.
First Author: Anna C. Pavlick
Poster
2016 ASCO Annual Meeting
A Phase II Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients with Malignant Melanoma Pre-Treated with Recombinant CDX-301, a Recombinant Human Flt3 Ligand.
First Author: Nina Bhardwaj
Poster
2020 ASCO Virtual Scientific Program
A phase II study of neoadjuvant pembrolizumab and lenvatinib for resectable stage III melanoma: The neopele study.
First Author: Maria Gonzalez
Poster
2016 ASCO Annual Meeting
Retrospective cohort analysis of adjuvant NY-ESO-1 vaccines in stage III melanoma.
First Author: Michael William Lattanzi